FREE Daily Stock Alerts From Stock-PR.com
libigrow.com has signed its first distribution agreement overseas.
"Libi Grow International Limited," the distributor, will purchase a minimum of $500,000 of products and serve a distribution area including Great Britain & the Republic of Ireland, Italy, Turkey, Germany & Switzerland.
Both companies have agreed to co-op advertising support and hyperlinks for their respective websites.
Alex Hbaiu, President & CEO of TRTB, stated, "This agreement is the first step in our efforts to bring the 'Libigrow' family of products to Europe and we are pleased to have strong local marketing experts to assist us."
TRTB announced recently the "Libigrow" family of products will have much larger production capacity as a result of a private placement of five million dollars.
The financing is at $0.20 per share and no warrants are attached. The first $2,300,000 has been subscribed and the first wire transfer order has been received. Accredited investor customers of True 2 Beauty and European Accredited investors are the subscribers. The company expects to have the offering over subscribed.
Proceeds will be used to increase TRTB 's Los Angeles manufacturing facility from its current one million pills per month to twenty million pills per month.
"This financing to expand our production will allow us to quickly fill our order backlog and to sign new orders from customers we met at this month's National Convenience Store Trade Show (NACS) which has 143,000 members in the United States." stated Alex Hbaiu.
TRTB is a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States. TRTB's line of current products includes Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink.
To learn more about TRTB visit: http://www.libigrow.com
Ingersoll-Rand plc (NYSE:IR)
IR, a world leader in creating and sustaining safe, comfortable and efficient environments, is pleased to announce the appointment of Robert L. Katz as senior vice president and general counsel, effective November 1, 2010. He joins Ingersoll Rand from Federal-Mogul Corporation where he served for four years as senior vice president, general counsel and corporate secretary.
Katz succeeds Patricia Nachtigal who will stay with the company during a transition period and retire in late December 2010. Nachtigal has been with Ingersoll Rand for 31 years, serving as general counsel for the last 19 years.
Ingles Markets Incorporated (NASDAQ:IMKTA)
IMKTA recently announced that its Board of Directors has declared a cash dividend of $0.165 (sixteen and one-half cents) per share on all its Class A Common Stock and $0.15 (fifteen cents) per share on all its Class B Common Stock. This is an annual rate of $0.66 and $0.60 per share, respectively. Dividends on both the Class A and Class B Common Stock are payable October 21, 2010, to all shareholders of record on October 7, 2010.
IMKTA is a leading supermarket chain with operations in six southeastern states. Headquartered in Asheville, North Carolina, IMKTA operates 202 supermarkets. In conjunction with its supermarket operations, IMKTA also operates 70 neighborhood shopping centers, all but 12 of which contain an Ingles supermarket. IMKTA's Class A Common Stock is traded on The NASDAQ Stock Market's Global Select Market under the symbol IMKTA.
Ingram Micro Inc. (NYSE:IM)
IM, the world's largest technology distributor and supply-chain services provider, is strengthening its focus on emerging technologies, global marketing opportunities and corporate social responsibility with adjustments to its worldwide executive team.
Sam Kamel is joining the company on October 25, 2010, as senior vice president, corporate strategy, with responsibility for planning, market analysis and business development, with particular emphasis on emerging technologies and adjacency opportunities. He will report to Greg Spierkel, chief executive officer, and become a member of the company's worldwide executive team and officer of the corporation.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received four thousand dollars in cash from a third party (Trinity International, LLC) for 1 day advertisement services for True 2 Beauty Inc. (TRTB.PK).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________Be Sure To Visit stock-pr.ning.com
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.